Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
Decoding ADC ADME With Tailored Strategies
Overcome the complex ADME and DDI challenges of antibody–drug conjugates with tailored, data-driven strategies that accelerate development and support regulatory success.
-
The Analytical Advantage Across The Development Lifecycle
Integrated, regulatory‑ready analytics help accelerate development, strengthen submissions, and ensure consistent product quality throughout the pharmaceutical lifecycle.
-
Screening For Amorphous Drug Substance
Incorporate amorphous form screening early in development to unlock solubility advantages, improve bioavailability, and accelerate your path to market.
-
Precision By Design: Drug Innovation Through Structure-Based Drug Design (SBDD)
Leverage structure-based drug design to gain deeper molecular insights, prioritize high-potential candidates, and accelerate your path from discovery to clinic.
-
What Everyone Needs To Know About Polymorphs
Build a strong foundation in solid form science — especially polymorphism — to reduce risk, control variability, and accelerate your path from development to reliable, cost-effective manufacturing.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
Integrated Drug Discovery: Hit To PCC In 16 Months
Accelerate your drug discovery program with integrated, cross-functional expertise that advances promising candidates from hit identification to preclinical development with speed and efficiency.
-
From 51% Yield To 87% With Targeted Impurity Removal
Targeted impurity identification and purification redesign dramatically improved yield, reduced process complexity, and enabled reliable API supply for Phase II clinical development.
-
Producing Quality APIs At Scale
Targeted process optimization transformed an early‑phase API with yield and impurity challenges into a scalable, high‑quality manufacturing process ready to support ongoing drug development.
-
Integrating High-Content Imaging With Traditional Plate-Based Screening
Gain mechanistic insights beyond traditional viability assays, revealing nuanced cellular phenotypes and strengthening early drug discovery decisions without sacrificing throughput or efficiency.
-
Accelerating Discovery Success With Structure-Guided Drug Design
Structure‑enabled drug discovery revealed a novel, druggable binding site in Artemis, enabling rapid SAR optimization and a ~500‑fold potency improvement against a challenging oncology target.
FORMULATION DEVELOPMENT SOLUTIONS
- High-Quality Filter Housings For Sanitary Applications
- MaxPeak Premier Columns For Peptide Analysis
- Granulated Materials: Easy Handling For Improved Process Efficiency
- The Digital Suite For Process Lifecycle Intelligence
- Speed, Scale, And Supply With Innovative Cell Culture Solutions
- R&D And Analytical Services
- Enhance Dissolution Rate With A Single High Performance Excipient
- Oligonucleotide Discovery And Development
- Automated Cell Imaging System
- Colon Intestine Bio-Kit
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- Compact & Powerful Double Planetary Mixer For Lab And Pilot-Scaling
- METTLER TOLEDO Strengthens Its Portfolio In The Americas And Europe With Eagle
- AES Cleanroom Technology appoints John Groth As Chief Revenue Officer
- Navigating Change: Key Industry Insights At PHARMAP 2026
- AbbVie Announces $1.4 Billion North Carolina Campus To Expand U.S. Pharmaceutical Manufacturing Capacity
- Contec, Inc.® Partners With i-team Global To Deliver Cleanroom-Certified, Battery-Powered Mechanized Cleaning System
- MECART Releases Highlights Of Peer-Reviewed Study Assessing Cleanroom Life-Cycle Environmental Impacts
- CDMO Nucleus RadioPharma Secures $50 Million Financing From OrbiMed to Expand Manufacturing Capacity
- Antares Vision Group To Present Denester-Inspection-Labeling Line For Prefilled Syringes At INTERPHEX 2026 Conference
- Achieve Life Sciences Announces Operational Progress Including Completion Of Technology Transfer To Adare Pharma Solutions